Valuation: Certara, Inc.

Market Cap 1.37B 1.22B 1.14B 1.03B 1.95B 132B 1.96B 13.69B 5.35B 67.24B 5.13B 5.02B 216B P/E 2026 *
-43.4x
P/E 2027 * 956x
Enterprise Value 1.43B 1.27B 1.19B 1.08B 2.03B 138B 2.05B 14.29B 5.58B 70.18B 5.36B 5.24B 226B EV / Sales 2026 *
3.76x
EV / Sales 2027 * 3.46x
Free-Float
67.08%
Yield 2026 *
-
Yield 2027 * -
1 day-3.34%
1 week-2.61%
Current month-2.61%
1 month+12.85%
3 months+24.97%
6 months+59.43%
Current year+1.70%
1 week 8.93
Extreme 8.93
10.19
1 month 7.31
Extreme 7.31
10.19
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.12
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO 53 15/07/2026
Chief Tech/Sci/R&D Officer - 31/07/2025
Director TitleAgeSince
Chairman 72 01/12/2021
Director/Board Member 68 01/01/2013
Director/Board Member 59 01/08/2017
Date Insider Type Main position Quantity % Market Cap. Importance
1/9/26 Free

Chief Financial Officer

63,532 0.0416%
15/7/26 Other

Chief Financial Officer

191,850 0.1233%
1/6/26 Exercice

General Counsel

57,763 0.0371%
Change 5-day change 1-year change 3-year change Capi.($)
-3.34%-2.61%-30.70%-37.69% 1.37B
+0.09%+3.29%+1.10%+61.88% 3,934B
+1.07%+3.78%+6.56%+1,068.69% 466B
-0.84%+4.56%-49.49%+30.56% 435B
-3.42%+2.08%+92.18%+228.81% 332B
-4.81%+0.26%+119.09%+500.92% 272B
+0.40%+1.07%-20.43%+54.40% 242B
-0.07%+2.88%-23.76%+22.94% 143B
-1.04%+5.88%+122.89%+215.84% 139B
-2.48%-0.92%+75.60%+187.35% 97.43B
Average -0.15%+2.08%+29.30%+233.37% 606.21B
Weighted average by Cap. +0.11%+3.14%+10.71%+170.27%

Financials

2026 *2027 *
Net sales 380M 339M 316M 287M 541M 36.72B 545M 3.8B 1.49B 18.68B 1.43B 1.39B 60.04B 390M 348M 325M 295M 556M 37.68B 560M 3.9B 1.52B 19.16B 1.46B 1.43B 61.61B
Net income -28.37M -25.35M -23.65M -21.48M -40.46M -2.74B -40.76M -284M -111M -1.4B -107M -104M -4.49B 1.74M 1.55M 1.45M 1.32M 2.48M 168M 2.5M 17.41M 6.8M 85.48M 6.52M 6.38M 275M
Net Debt 59.79M 53.42M 49.84M 45.27M 85.26M 5.78B 85.89M 599M 234M 2.94B 224M 220M 9.46B -19.92M -17.8M -16.61M -15.08M -28.41M -1.93B -28.62M -200M -77.97M -980M -74.79M -73.17M -3.15B
Projected Income Statement - Annual - Certara, Inc.
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.
Employees
1,546
Date Price Change Volume
07/10/26 USD 8.960 -3.34% 3,426,634
06/10/26 USD 9.270 -7.94% 3,946,120
05/10/26 USD 10.07 +7.59% 2,940,704
02/10/26 USD 9.360 +0.21% 2,645,999
01/10/26 USD 9.340 +1.52% 3,856,086
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Ratings Surperformance© - Certara, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
8.960USD
Average target price
8.623USD
Spread / Average Target
-3.76%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Certara, Inc.
  1. Stock Market
  2. Stocks
  3. CERT Stock